Metrifonate for Alzheimer's disease patients.
Schneider
L S
LS
D000544:Alzheimer Disease / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D002800:Cholinesterase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic / Q000592:standards; D003072:Cognition Disorders / Q000175:diagnosis / Q000188:drug therapy; D006801:Humans; D018908:Muscle Weakness / Q000139:chemically induced; D011569:Psychiatric Status Rating Scales / Q000706:statistics & numerical data; D012107:Research Design / Q000592:standards; D016896:Treatment Outcome; D014236:Trichlorfon / Q000009:adverse effects / Q000627:therapeutic use*
D002800:Cholinesterase Inhibitors; D014236:Trichlorfon